Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure

Running, not enrolling

Conditions studied: Heart Failure

In brief

To describe and compare the symptom burden in cancer patients with concurrent diagnosis of heart failure (HFrEF compared to HFpEF).

Key facts

Study ID

NCT06656715

Run by

M.D. Anderson Cancer Center

People needed

102

Starts

2024-12-16

Expected to finish

2028-09-01

Last updated by the study team

2026-07-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years and older
• Individuals with a concurrent solid tumor cancer diagnosis
• Not receiving active cancer treatment except for those on maintenance (i.e., Selective ER modulators (SERMs)[Tamoxifen], Aromatase inhibitors (Anastrozole, Letrozole, Exemestane), Ovarian suppression therapy (GnRH Agonists [Leuprolide], Androgen deprivation therapy for prostate cancer
• Completed cancer treatment at least 3 months and up to 3 years before study enrollment.
• Therapy
• Able to read, speak and consent in English
• Ability to understand and the willingness to sign a written informed consent document
• Diagnosis of heart failure, confirmed by echocardiogram, MUGA, or cardiac catheterization
• Internet access via smart phone, tablet, a computer, or another device with the capacity to 1) download the Fitbit App and 2) complete electronic study assessments via REDCap.

You may not qualify if…

• Participants undergoing active cancer treatment.
• Inability to provide consent in the medical record, such as cognitively impaired individuals.

Where it is running

• The University of Texas of MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.